Skip to main content
. 2021 Oct 29;10(Suppl):100796. doi: 10.1016/j.imr.2021.100796

Table 2.

The changes in primary and secondary outcomes from pretreatment to discharge

Outcome QARP group (n=64)
Standard therapies group (n=64)
Between-group difference (95% CI) P
Pre Post Difference Pre Post Difference
mMRC 2.9 (2.7, 3.1) 1.0 (0.9, 1.1) -1.8 (-2.1, 1.6)* 2.7 (2.5, 2.8) 1.1 (1.0, 1.3) -1.5 (-1.7, 1.3)* -0.3 (-0.6, 0.1)* 0.018
MBS 5.5 (4.9, 6.1) 1.7 (1.5, 1.9) -3.7 (-4.3, 3.2)* 5.3 (4.8, 5.8) 2.3 (1.9, 2.6) -3.1 (-3.5, 2.6)* -0.7 (-1.3, 0.0)* 0.045
FS-14 7.6 (6.8, 8.4) 3.8 (3.2, 4.4) -3.8 (-4.8, 2.8)* 7.2 (6.6, 7.9) 3.5 (2.9, 4.0) -3.8 (-4.7, 2.9)* -0.03 (-0.7, 0.7) 0.931
PHQ-9 13.3 (12.0, 14.7) 7.1 (6.2, 8.0) -6.5 (-8.1, 5.0)* 13.7 (12.3, 15.0) 6.6 (5.6, 7.6) -7.0 (-8.7, 5.4)* 0.5 (-1.0, 2.1) 0.492
Temperature,°C 37.5 (37.3, 37.8) 36.5 (36.4, 36.6) -1.0 (-1.3, -0.8) * 37.4 (37.2, 37.6) 36.5 (36.4, 36.5) -0.9 (-1.1, -0.7)* 0.0 (-0.08, 0.09) 0.914
Heart rate (bpm) 85.5 (82.7, 88.4) 81.2 (79.4, 83.0) -4.4 (-7.7, -1.0)* 85.4 (82.3, 88.5) 80.7 (78.0, 83.3) -4.7 (-8.8, -0.7)* 0.3 (-2.6, 3.6) 0.754
Respiration rate (times/min) 23.1 (20.6, 25.6) 19.9 (19.6, 20.3) -3.1 (-5.6, -0.6) * 22.6 (21.6, 23.6) 21.9 (19.8, 24.0) -1.7 (-3.0, 1.5)* -1.4 (-4.2, 1.3) 0.301
Systolic blood pressure (mmHg) 124.2 (121.9, 126.6) 120.3 (117.8, 122.8) -3.9 (- 7.3, -0.5)* 123.3 (119.9, 126.6) 123.6 (121.0, 126.3) 0.3 (- 3.9, 4.6) -4.2 (-9.4, -0.9) 0.108
Diastolic blood pressure (mmHg) 73.0 (70.7, 75.3) 73.2 (71.2, 75.2) 0.3 (-2.8, 3.3) 72.5 (70.2, 74.9) 74.0 (71.8, 76.1) 1.4 (-1.7, 4.6) -1.1 (-4.9, 2.6) 0.537
Blood oxygen saturation (SaO2) 92.7 (92.1, 93.2) 97.0 (96.5, 97.4) 4.3 (3.6, 5.0)* 92.8 (92.1, 93.5) 97.0 (96.4, 97.6) 4.2 (3.3, 5.1)* 0.0 (-0.8, 0.7) 0.967

*, p<0.05. MBS, modified Borg dyspnea scale; FS-14, Fatigue Scale-14; PHQ-9, Patient Health Questionnaire-9 scale; mMRC, Medical Research Council; QARP, Qigong exercise and acupressure telerehabilitation program; SaO2, oxygen saturation; COVID-19, coronavirus disease of 2019; CI, confidence intervals.

HHS Vulnerability Disclosure